Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis - Zheng, SL; Roddick, AJ; Aghar-Jaffar, R; Shun-Shin, MJ; Francis, D; Oliver, N; Meeran, K (JAMA: Journal of the American Medical Association, 2018)